CRISPR THERAPEUTIC earnings per share and revenue

1CG earnings per share for the last quarter are -0.40 CHF whereas the estimation was -1.09 CHF which accounts for 63.35% surprise. Company revenue for the same period amounts to 32.41 M CHF despite the estimated figure of 7.32 M CHF. Estimated earnings per share for the next quarter are -1.16 CHF, and revenue is expected to reach 6.95 M CHF. Also watch annual changes over time to get a bigger picture of 1CG earnings per share and revenue dynamics.